Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
As of close of business last night, Checkpoint Therapeutics Inc’s stock clocked out at $2.95, down -5.75% from its previous closing price of $3.13. In other words, the price has decreased by -$5.75 from its previous closing price. On the day, 0.76 million shares were traded.
Ratios:
To gain a deeper understanding of CKPT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.29 and its Current Ratio is at 0.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, D. Boral Capital on January 13, 2025, initiated with a Buy rating and assigned the stock a target price of $9.
On June 09, 2021, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $18.B. Riley Securities initiated its Buy rating on June 09, 2021, with a $18 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 10 ’25 when Oliviero James F III sold 10,331 shares for $3.15 per share. The transaction valued at 32,543 led to the insider holds 3,775,019 shares of the business.
Oliviero James F III sold 9,233 shares of CKPT for $31,485 on Feb 07 ’25. The CEO, President and Director now owns 3,785,350 shares after completing the transaction at $3.41 per share. On Feb 06 ’25, another insider, GRAY WILLIAM GARRETT, who serves as the Chief Financial Officer of the company, sold 74,110 shares for $3.67 each. As a result, the insider received 271,984 and left with 1,458,644 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2881.20.
Stock Price History:
Over the past 52 weeks, CKPT has reached a high of $4.50, while it has fallen to a 52-week low of $1.38. The 50-Day Moving Average of the stock is -11.05%, while the 200-Day Moving Average is calculated to be 8.09%.
Shares Statistics:
A total of 45.10M shares are outstanding, with a floating share count of 35.94M. Insiders hold about 26.39% of the company’s shares, while institutions hold 22.05% stake in the company.
Earnings Estimates
Checkpoint Therapeutics Inc (CKPT) is presently subject to a detailed evaluation by 1 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.1 and low estimates of -$0.1.
Analysts are recommending an EPS of between -$0.86 and -$0.86 for the fiscal current year, implying an average EPS of -$0.86. EPS for the following year is $0.27, with 1.0 analysts recommending between $0.27 and $0.27.
Revenue Estimates
Based on 2 analysts’ estimates, the company’s revenue will be $41.11M in the next fiscal year. The high estimate is $72.83M and the low estimate is $9.4M.
